Forest plot showing the ratio of odds of acute side effects: nausea (a) and vomiting (b) (=events) among pediatric patients with brain tumors treated with PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the odds of 5-year overall-survival rate among children with brain tumors treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Data_table_with_all_identified_articles_31-JAN-2025. by Renáta Kiss-Miki (20760127)

Subjects:

Data_extraction_table_31-JAN-2025. by Renáta Kiss-Miki (20760127)

Subjects:

Forest plot showing the ratio of odds of grade 3 anemia (=event) among pediatric patients with brain tumors treated with either PT or XRT. by Renáta Kiss-Miki (20760127)

Subjects:

Mean and SDs of the significant regions. by Faran Sabeti (6166766)

Subjects:

Intensity comparation of significantly changed metabolites of four groups of control, model, YYD and RER groups. by Guanwen Gong (9693076)

Hedgehog and steroidogenic pathway genes are decreased in <i>Gli3</i>^<i>XtJ</i> testes. by Anbarasi Kothandapani (8934590)

Significant differences between Th17-cell levels of dogs suffering from IVDH at all three sampling time points and in comparison with the healthy control group. by Annika Kämpe (11507012)

Scheffe post-hoc. by Nina Brkić-Jovanović (18886883)

“…During the one-year follow-up of persons on INSTI-based regimen, no significant changes in cognitive achievement were recorded, which suggests that the existing therapy can have a potentially positive effect on the maintenance of neurocognitive achievement.…”

MANCOVA’s main and interactive effect results. by Nina Brkić-Jovanović (18886883)

“…During the one-year follow-up of persons on INSTI-based regimen, no significant changes in cognitive achievement were recorded, which suggests that the existing therapy can have a potentially positive effect on the maintenance of neurocognitive achievement.…”

S1 File - by Nina Brkić-Jovanović (18886883)

“…During the one-year follow-up of persons on INSTI-based regimen, no significant changes in cognitive achievement were recorded, which suggests that the existing therapy can have a potentially positive effect on the maintenance of neurocognitive achievement.…”

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Combined Quantitative (Phospho)proteomics and Mass Spectrometry Imaging Reveal Temporal and Spatial Protein Changes in Human Intestinal Ischemia–Reperfusion by Anna M. Kip (11804493)

Subjects:

DHA decreased cell viability in HepG3 cells. by Arlet Hernandez (12289155)

<i>In vivo</i> voxel based morphometry identified areas of significant enlargement in trained animals relative to the controls. by Alexandra Badea (352052)

Shows 48/86 genes have differential expression consistent with the direction of decrease in cell movement. by Afrooz Jahedi (14636554)

<i>Kdm6a</i> conditional KO mice have decreased repopulating potential in serial competitive transplantation assays. by Ling Tian (107492)

“…(E) Quantification of donor cell chimerism of HSCs in BM by flow cytometry 18 weeks after secondary transplantation. Significant differences in the chimerism of SLAM cells compared to whole BM were found in KO-F mice (55.2-fold increase in CD45.2⁺ KO-F SLAM cells as compared to CD45.2⁺ cells in the whole BM, p = 0.0163) and KO-M mice (11.31-fold increase in CD45.2⁺ KO-M SLAM cells as compared to CD45.2⁺ cells in the whole BM, p = 0.0010). …”

Stratified results for parental stressors. by Ragnhild Bjørknes (4908577)

Subjects:

Stratified results for parental stressors and parental rewards. by Ragnhild Bjørknes (4908577)

Subjects: